MERUS B.V.

HQ - Utrecht

Summary

Merus N.V. is a clinical-stage immuno-oncology company focused on developing innovative full-length bispecific antibody therapeutics.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 5.91 B

Avg. Deal Size£ 2.96 B

Market Context

Senior Management